YM
Yann Mazabraud
EVP, Head of International

Yann Mazabraud insider trades: Rhythm Pharmaceuticals (RYTM) stock sales

EVP, Head of International, Rhythm Pharmaceuticals Last trade Aug 12, 2026 26 Form 4 filings
$6.6M
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2022
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Yann reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 12, 2026RYTM↓ Sell$6.6M
Apr 29, 2025RYTM↓ Sell$439K
Apr 8, 2025RYTM↓ Sell$1.1M
Mar 14, 2025RYTM↓ Sell$3.9M
Mar 19, 2024RYTM↓ Sell$628K
Feb 13, 2024RYTM↓ Sell$130K
Feb 14, 2023RYTM↓ Sell$32K
Feb 9, 2023RYTM↓ Sell$43K
Feb 15, 2022RYTM↓ Sell$6K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RYTM insiders

Open-market trades in the last 12 months

About Yann Mazabraud's insider trades

Yann Mazabraud is EVP, Head of International at Rhythm Pharmaceuticals (RYTM). Since Feb 15, 2022, Yann has reported no open-market purchases and 9 sales worth $12.8M on SEC Form 4. In the last 12 months: 1 sale ($6.6M).

Their filings also include option exercises (12 filings), grants and awards (12 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RYTM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.